Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ILMN vs GSK✓SelectedUSD · GSKILMN vs GSK performance historyLatest closeAs of+3.65%11/18
Stock and ETF performance explorer

ILMN vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+63.7%
GSK return
+101.2%
Excess return
-37.5%
Maximum drawdown
-86.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.7%-1.3%+5.0%+4.2%
7D-1.4%-3.1%+1.8%-0.1%
30D-20.0%-0.9%-19.2%-20.2%
3M+11.5%-4.2%+15.7%+12.8%
6M+48.4%-1.6%+50.0%+47.3%
YTD+60.1%+2.6%+57.5%+54.3%
1Y+72.2%+6.2%+66.0%+63.1%
3Y+128.9%+55.0%+73.9%+74.2%
5Y-42.6%+42.8%-85.4%-55.4%
10Y+63.7%+102.1%-38.4%+2.6%
All+63.7%+101.2%-37.5%+2.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling